Demonstrated that BPC-157 improves insulin signaling and reduces TNF- and IL-6 release in hepatocyte cultures exposed to high-glucose conditions, providing a new model for studying metabolic-dysfunction pathways
The compound is not FDA-approved for human use and is sold for research purposes only
Fluorescence microscopy studies have documented rapid cellular accumulation, with detectable intracellular concentrations within 30 minutes of external application at physiological concentrations
Where peptides do show promise in skin The positive evidence is strongest for selected topical signal peptides, although the improvements tend to be modest and the studies are often small, short-term or industry-associated
These include symptomatic improvement, notably in sputum characteristics, i.e., it reduces viscosity and volume ( 1 ) and Peak Expiratory Flow Rate (PEFR) ( Initial studies utilizing low-dose NAC (600 mg/day) yielded promising results, prompting the initiation of larger multicenter RCTs focused on GOLD-defined COPD patients
And that if I can offer affordable membership options to patients, then I feel like its a win-win situation because they can be seen for the time that they need to be seen